The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
Open accessAbstract
Meningiomas are mostly benign brain tumours, with a potential for becoming atypical or malignant. On the basis of comprehensive genomic, transcriptomic and epigenomic analyses, we compared benign meningiomas to atypical ones. Here, we show that the majority of primary (de novo) atypical meningiomas display loss of NF2, which co-occurs either with genomic instability or recurrent SMARCB1 mutations. These tumours harbour increased H3K27me3 signal and a hypermethylated phenotype, mainly occupying the polycomb repressive complex 2 (PRC2) binding sites in human embryonic stem cells, thereby phenocopying a more primitive cellular state. Consistent with this observation, atypical meningiomas exhibit upregulation of EZH2, the catalytic subunit of the PRC2 complex, as well as the E2F2 and FOXM1 transcriptional networks. Importantly, these primary atypical meningiomas do not harbour TERT promoter mutations, which have been reported in atypical tumours that progressed from benign ones. Our results establish the genomic landscape of primary atypical meningiomas and potential therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
GREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Self-citationCOSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Cited by
A clinically applicable integrative molecular classification of meningiomas
Nassiri, F., Liu, J., Patil, V., Mamatjan, Y., Wang, J. Z., Hugh-White, R., Macklin, A. M., Khan, S., Singh, O., Karimi, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03850-3 · Cited by 449
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Choudhury, A., Magill, S. T., Eaton, C. D., Prager, B. C., Chen, W. C., Cady, M. A., Seo, K., Lucas, C.-H. G., Casey-Clyde, T. J., Vasudevan, H. N., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01061-8 · Cited by 293
Nassiri, F., Mamatjan, Y., Suppiah, S., Badhiwala, J. H., Mansouri, S., Karimi, S., Saarela, O., Poisson, L., Gepfner-Tuma, I., Schittenhelm, J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz061 · Cited by 267
Self-citationMaas, S. L. N., Stichel, D., Hielscher, T., Sievers, P., Berghoff, A. S., Schrimpf, D., Sill, M., Euskirchen, P., Blume, C., Patel, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00784 · Cited by 261
Machine Learning Protocol for Surface-Enhanced Raman Spectroscopy
Hu, W., Ye, S., Zhang, Y., Li, T., Zhang, G., Luo, Y., Mukamel, S., & Jiang, J. (2019) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.9b02517 · Cited by 92
Metadata
- Authors
- Harmancı, A. S., Youngblood, M. W., Clark, V. E., Coşkun, S., Henegariu, O., Duran, D., Erson-Omay, E. Z., Kaulen, L. D., Lee, T. I., Abraham, B. J., Simon, M., Krischek, B., Timmer, M., Goldbrunner, R., Omay, S. B., Baranoski, J., Baran, B., Carrión-Grant, G., Bai, H., Mishra-Gorur, K., Schramm, J., Moliterno, J., Vortmeyer, A. O., Bilgüvar, K., Yasuno, K., Young, R. A., & Günel, M.
- Venue
- Nature Communications
- Published
- 2017-02-14
- Volume
- 8
- Issue
- 1
- Pages
- 14433-14433
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2588593526
- Cited by
- 213
- References
- 9
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrated genomic analyses of de novo pathways underlying atypical meningiomas. https://app.cochat.ai/papers/10.1038/ncomms14433
- The paper
- Harmancı, A. S., Youngblood, M. W., Clark, V. E., Coşkun, S., Henegariu, O., Duran, D., Erson-Omay, E. Z., Kaulen, L. D., Lee, T. I., Abraham, B. J., Simon, M., Krischek, B., Timmer, M., Goldbrunner, R., Omay, S. B., Baranoski, J., Baran, B., Carrión-Grant, G., Bai, H., . . . Günel, M. (2017). Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nature Communications. https://doi.org/10.1038/ncomms14433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.